FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for Visine Allergy Eye Relief Multi-Action, a combination of naphazoline hydrochloride and pheniramine maleate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• VISINE ALLERGY EYE RELIEF MULTI-ACTION (Naphazoline hydrochloride and pheniramine maleate)

Snippet

SUPPL AP for VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)